Imidocarb is a urea derivative used in veterinary medicine as an antiprotozoal agent for the treatment of infection with Babesia (babesiosis) and other parasites.[1][2][3]

Mechanism of action

Imidocarb is anticholinergic; it inhibits acetylcholinesterase.[4][5]

References

  1. ^ Hashemi-Fesharki, R (1977). "Studies on imidocarb dihydrochloride in experimental Babesia ovis infection in splenectomized lambs". The British Veterinary Journal. 133 (6): 609–14. doi:10.1016/S0007-1935(17)33941-6. PMID 608109.
  2. ^ Hashemi-Fesharki, R (1975). "Studies on imidocarb dihydrochloride in experimental Babesia bigemina infection in calves". The British Veterinary Journal. 131 (6): 666–72. doi:10.1016/S0007-1935(17)35138-2. PMID 1212605.
  3. ^ Kuttler, KL (1980). "Pharmacotherapeutics of drugs used in treatment of anaplasmosis and babesiosis". Journal of the American Veterinary Medical Association. 176 (10 Spec No): 1103–8. PMID 7216881.
  4. ^ "Imidocarb". DrugBank. Retrieved November 23, 2024.
  5. ^ Papich, Mark G. (2016). Saunders Handbook of Veterinary Drugs (4th ed.). Elsevier. pp. 391–392. doi:10.1016/B978-0-323-24485-5.00304-1. ISBN 978-0-323-24485-5.


Allikas: http://en.wikipedia.org/wiki/Imidocarb
No tags for this post.